- Home
- SSSS vs VOR Comparison
SSSS vs VOR Comparison
Compare SSSS & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$13.60
Company Overview
Basic Information| Metric | SSSS | VOR |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 207.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SSSS | VOR |
|---|---|---|
| Price | $9.46 | $13.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $10.13 | ★ $66.63 |
| AVG Volume (30 Days) | 137.4K | ★ 3.7M |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | ★ 10.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $2,354,933.00 | N/A |
| Revenue This Year | $7,183.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.76 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.21 | $2.62 |
| 52 Week High | $10.34 | $65.80 |
Technical Indicators
Market Signals| Indicator | SSSS | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 53.10 |
| Support Level | $9.17 | $10.29 |
| Resistance Level | $9.92 | $13.60 |
| Average True Range (ATR) | 0.27 | 1.68 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 51.16 | 50.08 |
Price Performance
Historical Comparison SSSS
VOR
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.